TETRAPHASE PHARMACEUTICALS I's ticker is TTPH and the CUSIP is 88165N204. A total of 23 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,000 | – | 4,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 208,074 | $524,000 | 0.19% |
| ARMISTICE CAPITAL, LLC | 1,419,507 | $3,577,000 | 0.16% |
| Tekla Capital Management LLC | 42,965 | $108,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30,000 | $76,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 78,218 | $197,000 | 0.00% |
| UBS Group AG | 2,925 | $7,000 | 0.00% |
| Sargent Bickham Lagudis LLC | 1,000 | $3,000 | 0.00% |
| Sowell Financial Services LLC | 1 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 150 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,664 | $32,000 | 0.00% |